nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—Methoxsalen—hematologic cancer	0.0684	0.122	CbGbCtD
Pentobarbital—CYP2A6—Ifosfamide—hematologic cancer	0.0499	0.0889	CbGbCtD
Pentobarbital—CYP2A6—Prednisolone—hematologic cancer	0.0332	0.0592	CbGbCtD
Pentobarbital—CYP2C19—Bortezomib—hematologic cancer	0.0269	0.0479	CbGbCtD
Pentobarbital—CHRFAM7A—ovarian follicle—hematologic cancer	0.0246	0.318	CbGeAlD
Pentobarbital—CYP2C19—Thalidomide—hematologic cancer	0.0234	0.0418	CbGbCtD
Pentobarbital—CYP2C19—Teniposide—hematologic cancer	0.0224	0.0398	CbGbCtD
Pentobarbital—CYP3A4—Bexarotene—hematologic cancer	0.0212	0.0378	CbGbCtD
Pentobarbital—CYP2C19—Ifosfamide—hematologic cancer	0.0206	0.0368	CbGbCtD
Pentobarbital—CHRNA7—ovarian follicle—hematologic cancer	0.0198	0.257	CbGeAlD
Pentobarbital—CYP3A4—Lomustine—hematologic cancer	0.0197	0.0352	CbGbCtD
Pentobarbital—CYP3A4—Busulfan—hematologic cancer	0.0197	0.0352	CbGbCtD
Pentobarbital—CYP2C19—Imatinib—hematologic cancer	0.0197	0.0351	CbGbCtD
Pentobarbital—CYP2A6—Dexamethasone—hematologic cancer	0.0196	0.0349	CbGbCtD
Pentobarbital—CYP3A4—Thiotepa—hematologic cancer	0.0176	0.0313	CbGbCtD
Pentobarbital—CYP3A4—Methoxsalen—hematologic cancer	0.0137	0.0244	CbGbCtD
Pentobarbital—CYP3A4—Bortezomib—hematologic cancer	0.013	0.0232	CbGbCtD
Pentobarbital—CYP2C19—Prednisone—hematologic cancer	0.013	0.0231	CbGbCtD
Pentobarbital—CYP3A4—Daunorubicin—hematologic cancer	0.0124	0.0222	CbGbCtD
Pentobarbital—CYP3A4—Cytarabine—hematologic cancer	0.011	0.0196	CbGbCtD
Pentobarbital—CYP3A4—Teniposide—hematologic cancer	0.0108	0.0193	CbGbCtD
Pentobarbital—CYP3A4—Ifosfamide—hematologic cancer	0.00997	0.0178	CbGbCtD
Pentobarbital—CYP3A4—Imatinib—hematologic cancer	0.00953	0.017	CbGbCtD
Pentobarbital—CYP3A4—Ruxolitinib—hematologic cancer	0.00897	0.016	CbGbCtD
Pentobarbital—CYP3A4—Nilotinib—hematologic cancer	0.00866	0.0154	CbGbCtD
Pentobarbital—CYP3A4—Vinorelbine—hematologic cancer	0.00858	0.0153	CbGbCtD
Pentobarbital—CYP2C19—Dexamethasone—hematologic cancer	0.0081	0.0144	CbGbCtD
Pentobarbital—CYP3A4—Triamcinolone—hematologic cancer	0.00785	0.014	CbGbCtD
Pentobarbital—CYP3A4—Dasatinib—hematologic cancer	0.00765	0.0136	CbGbCtD
Pentobarbital—CYP3A4—Mitoxantrone—hematologic cancer	0.00756	0.0135	CbGbCtD
Pentobarbital—CYP3A4—Betamethasone—hematologic cancer	0.00674	0.012	CbGbCtD
Pentobarbital—CYP3A4—Prednisolone—hematologic cancer	0.00665	0.0118	CbGbCtD
Pentobarbital—CYP3A4—Prednisone—hematologic cancer	0.00628	0.0112	CbGbCtD
Pentobarbital—CYP3A4—Irinotecan—hematologic cancer	0.00595	0.0106	CbGbCtD
Pentobarbital—CYP3A4—Vinblastine—hematologic cancer	0.00529	0.00943	CbGbCtD
Pentobarbital—CYP3A4—Vincristine—hematologic cancer	0.0052	0.00927	CbGbCtD
Pentobarbital—CYP3A4—Etoposide—hematologic cancer	0.00477	0.00849	CbGbCtD
Pentobarbital—CYP3A4—Dexamethasone—hematologic cancer	0.00392	0.00698	CbGbCtD
Pentobarbital—CYP3A4—Doxorubicin—hematologic cancer	0.00325	0.00579	CbGbCtD
Pentobarbital—CHRFAM7A—hematopoietic system—hematologic cancer	0.00297	0.0384	CbGeAlD
Pentobarbital—CHRNA7—hematopoietic system—hematologic cancer	0.0024	0.031	CbGeAlD
Pentobarbital—CHRNA4—hematopoietic system—hematologic cancer	0.00236	0.0306	CbGeAlD
Pentobarbital—CHRFAM7A—blood—hematologic cancer	0.00196	0.0254	CbGeAlD
Pentobarbital—GRIA2—testis—hematologic cancer	0.00178	0.0231	CbGeAlD
Pentobarbital—GABRA5—testis—hematologic cancer	0.00167	0.0216	CbGeAlD
Pentobarbital—CHRFAM7A—testis—hematologic cancer	0.00163	0.021	CbGeAlD
Pentobarbital—CHRNA7—blood—hematologic cancer	0.00159	0.0205	CbGeAlD
Pentobarbital—GABRA3—testis—hematologic cancer	0.00156	0.0201	CbGeAlD
Pentobarbital—CYP2C19—hematopoietic system—hematologic cancer	0.00154	0.0199	CbGeAlD
Pentobarbital—CYP2A6—lung—hematologic cancer	0.00139	0.018	CbGeAlD
Pentobarbital—CHRNA4—lung—hematologic cancer	0.00137	0.0178	CbGeAlD
Pentobarbital—GABRB3—gonad—hematologic cancer	0.00135	0.0175	CbGeAlD
Pentobarbital—GABRB2—lung—hematologic cancer	0.00134	0.0174	CbGeAlD
Pentobarbital—CHRNA7—testis—hematologic cancer	0.00131	0.017	CbGeAlD
Pentobarbital—GABRB2—testis—hematologic cancer	0.00127	0.0164	CbGeAlD
Pentobarbital—GABRB3—lung—hematologic cancer	0.00103	0.0134	CbGeAlD
Pentobarbital—CYP2C19—blood—hematologic cancer	0.00102	0.0132	CbGeAlD
Pentobarbital—GABRB3—testis—hematologic cancer	0.000974	0.0126	CbGeAlD
Pentobarbital—CYP3A4—hematopoietic system—hematologic cancer	0.00091	0.0118	CbGeAlD
Pentobarbital—GABRA2—lymph node—hematologic cancer	0.00084	0.0109	CbGeAlD
Pentobarbital—CYP3A4—blood—hematologic cancer	0.000603	0.0078	CbGeAlD
Pentobarbital—Dizziness—Hydroxyurea—hematologic cancer	0.000207	0.000772	CcSEcCtD
Pentobarbital—Feeling abnormal—Alitretinoin—hematologic cancer	0.000207	0.00077	CcSEcCtD
Pentobarbital—Constipation—Vincristine—hematologic cancer	0.000207	0.00077	CcSEcCtD
Pentobarbital—Rash—Melphalan—hematologic cancer	0.000206	0.000768	CcSEcCtD
Pentobarbital—Dermatitis—Melphalan—hematologic cancer	0.000206	0.000767	CcSEcCtD
Pentobarbital—Feeling abnormal—Ifosfamide—hematologic cancer	0.000204	0.000761	CcSEcCtD
Pentobarbital—Nausea—Vinblastine—hematologic cancer	0.000204	0.00076	CcSEcCtD
Pentobarbital—Somnolence—Gemcitabine—hematologic cancer	0.000204	0.00076	CcSEcCtD
Pentobarbital—Vomiting—Lenalidomide—hematologic cancer	0.000202	0.000753	CcSEcCtD
Pentobarbital—Constipation—Mitoxantrone—hematologic cancer	0.000201	0.00075	CcSEcCtD
Pentobarbital—Constipation—Irinotecan—hematologic cancer	0.000201	0.00075	CcSEcCtD
Pentobarbital—Bradycardia—Prednisone—hematologic cancer	0.000201	0.000749	CcSEcCtD
Pentobarbital—Hypersensitivity—Thiotepa—hematologic cancer	0.000201	0.000748	CcSEcCtD
Pentobarbital—Rash—Lenalidomide—hematologic cancer	0.0002	0.000746	CcSEcCtD
Pentobarbital—Body temperature increased—Carmustine—hematologic cancer	0.0002	0.000746	CcSEcCtD
Pentobarbital—Dermatitis—Lenalidomide—hematologic cancer	0.0002	0.000746	CcSEcCtD
Pentobarbital—Hypotension—Cisplatin—hematologic cancer	0.0002	0.000744	CcSEcCtD
Pentobarbital—Vomiting—Hydroxyurea—hematologic cancer	0.000199	0.000742	CcSEcCtD
Pentobarbital—Headache—Lenalidomide—hematologic cancer	0.000199	0.000742	CcSEcCtD
Pentobarbital—Angioedema—Triamcinolone—hematologic cancer	0.000199	0.000741	CcSEcCtD
Pentobarbital—Body temperature increased—Alitretinoin—hematologic cancer	0.000198	0.000739	CcSEcCtD
Pentobarbital—Rash—Hydroxyurea—hematologic cancer	0.000197	0.000736	CcSEcCtD
Pentobarbital—Confusional state—Etoposide—hematologic cancer	0.000197	0.000736	CcSEcCtD
Pentobarbital—Dermatitis—Hydroxyurea—hematologic cancer	0.000197	0.000735	CcSEcCtD
Pentobarbital—Hallucination—Prednisone—hematologic cancer	0.000196	0.000732	CcSEcCtD
Pentobarbital—Headache—Hydroxyurea—hematologic cancer	0.000196	0.000731	CcSEcCtD
Pentobarbital—Constipation—Gemcitabine—hematologic cancer	0.000196	0.000731	CcSEcCtD
Pentobarbital—Body temperature increased—Ifosfamide—hematologic cancer	0.000196	0.00073	CcSEcCtD
Pentobarbital—Syncope—Triamcinolone—hematologic cancer	0.000195	0.000727	CcSEcCtD
Pentobarbital—Ataxia—Doxorubicin—hematologic cancer	0.000194	0.000724	CcSEcCtD
Pentobarbital—Hypersensitivity—Thalidomide—hematologic cancer	0.000194	0.000724	CcSEcCtD
Pentobarbital—Nausea—Melphalan—hematologic cancer	0.000194	0.000723	CcSEcCtD
Pentobarbital—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000194	0.000723	CcSEcCtD
Pentobarbital—Feeling abnormal—Irinotecan—hematologic cancer	0.000194	0.000723	CcSEcCtD
Pentobarbital—Dizziness—Bortezomib—hematologic cancer	0.000193	0.00072	CcSEcCtD
Pentobarbital—Loss of consciousness—Triamcinolone—hematologic cancer	0.000191	0.000713	CcSEcCtD
Pentobarbital—Body temperature increased—Vincristine—hematologic cancer	0.000191	0.000712	CcSEcCtD
Pentobarbital—Shock—Prednisolone—hematologic cancer	0.00019	0.000708	CcSEcCtD
Pentobarbital—Feeling abnormal—Gemcitabine—hematologic cancer	0.000189	0.000704	CcSEcCtD
Pentobarbital—Dizziness—Vinorelbine—hematologic cancer	0.000189	0.000703	CcSEcCtD
Pentobarbital—Nausea—Lenalidomide—hematologic cancer	0.000189	0.000703	CcSEcCtD
Pentobarbital—Hypersensitivity—Carmustine—hematologic cancer	0.000186	0.000695	CcSEcCtD
Pentobarbital—Body temperature increased—Irinotecan—hematologic cancer	0.000186	0.000693	CcSEcCtD
Pentobarbital—Body temperature increased—Mitoxantrone—hematologic cancer	0.000186	0.000693	CcSEcCtD
Pentobarbital—Nausea—Hydroxyurea—hematologic cancer	0.000186	0.000693	CcSEcCtD
Pentobarbital—Vomiting—Bortezomib—hematologic cancer	0.000186	0.000693	CcSEcCtD
Pentobarbital—Hypersensitivity—Alitretinoin—hematologic cancer	0.000185	0.000689	CcSEcCtD
Pentobarbital—Vomiting—Bleomycin—hematologic cancer	0.000184	0.000687	CcSEcCtD
Pentobarbital—Rash—Bortezomib—hematologic cancer	0.000184	0.000687	CcSEcCtD
Pentobarbital—Dermatitis—Bortezomib—hematologic cancer	0.000184	0.000686	CcSEcCtD
Pentobarbital—Headache—Bortezomib—hematologic cancer	0.000183	0.000682	CcSEcCtD
Pentobarbital—Hypotension—Etoposide—hematologic cancer	0.000183	0.000682	CcSEcCtD
Pentobarbital—Rash—Bleomycin—hematologic cancer	0.000183	0.000682	CcSEcCtD
Pentobarbital—Dermatitis—Bleomycin—hematologic cancer	0.000183	0.000681	CcSEcCtD
Pentobarbital—Hypersensitivity—Ifosfamide—hematologic cancer	0.000183	0.000681	CcSEcCtD
Pentobarbital—Vomiting—Vinorelbine—hematologic cancer	0.000181	0.000676	CcSEcCtD
Pentobarbital—Body temperature increased—Gemcitabine—hematologic cancer	0.000181	0.000675	CcSEcCtD
Pentobarbital—Angioedema—Betamethasone—hematologic cancer	0.00018	0.000672	CcSEcCtD
Pentobarbital—Angioedema—Dexamethasone—hematologic cancer	0.00018	0.000672	CcSEcCtD
Pentobarbital—Dizziness—Thiotepa—hematologic cancer	0.00018	0.000672	CcSEcCtD
Pentobarbital—Rash—Vinorelbine—hematologic cancer	0.00018	0.000671	CcSEcCtD
Pentobarbital—Dermatitis—Vinorelbine—hematologic cancer	0.00018	0.00067	CcSEcCtD
Pentobarbital—Headache—Vinorelbine—hematologic cancer	0.000179	0.000666	CcSEcCtD
Pentobarbital—Hypersensitivity—Vincristine—hematologic cancer	0.000178	0.000664	CcSEcCtD
Pentobarbital—Syncope—Betamethasone—hematologic cancer	0.000177	0.00066	CcSEcCtD
Pentobarbital—Syncope—Dexamethasone—hematologic cancer	0.000177	0.00066	CcSEcCtD
Pentobarbital—Feeling abnormal—Cisplatin—hematologic cancer	0.000176	0.000656	CcSEcCtD
Pentobarbital—Shock—Triamcinolone—hematologic cancer	0.000175	0.000651	CcSEcCtD
Pentobarbital—Dizziness—Thalidomide—hematologic cancer	0.000174	0.00065	CcSEcCtD
Pentobarbital—Somnolence—Etoposide—hematologic cancer	0.000174	0.000649	CcSEcCtD
Pentobarbital—Nausea—Bortezomib—hematologic cancer	0.000173	0.000647	CcSEcCtD
Pentobarbital—Loss of consciousness—Dexamethasone—hematologic cancer	0.000173	0.000647	CcSEcCtD
Pentobarbital—Loss of consciousness—Betamethasone—hematologic cancer	0.000173	0.000647	CcSEcCtD
Pentobarbital—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000173	0.000646	CcSEcCtD
Pentobarbital—Hypersensitivity—Irinotecan—hematologic cancer	0.000173	0.000646	CcSEcCtD
Pentobarbital—Vomiting—Thiotepa—hematologic cancer	0.000173	0.000646	CcSEcCtD
Pentobarbital—Nausea—Bleomycin—hematologic cancer	0.000172	0.000642	CcSEcCtD
Pentobarbital—Rash—Thiotepa—hematologic cancer	0.000172	0.00064	CcSEcCtD
Pentobarbital—Dermatitis—Thiotepa—hematologic cancer	0.000172	0.00064	CcSEcCtD
Pentobarbital—Headache—Thiotepa—hematologic cancer	0.000171	0.000636	CcSEcCtD
Pentobarbital—Nausea—Vinorelbine—hematologic cancer	0.000169	0.000632	CcSEcCtD
Pentobarbital—Body temperature increased—Cisplatin—hematologic cancer	0.000169	0.00063	CcSEcCtD
Pentobarbital—Vomiting—Thalidomide—hematologic cancer	0.000167	0.000625	CcSEcCtD
Pentobarbital—Anxiety—Betamethasone—hematologic cancer	0.000167	0.000624	CcSEcCtD
Pentobarbital—Anxiety—Dexamethasone—hematologic cancer	0.000167	0.000624	CcSEcCtD
Pentobarbital—Dizziness—Carmustine—hematologic cancer	0.000167	0.000624	CcSEcCtD
Pentobarbital—Constipation—Etoposide—hematologic cancer	0.000167	0.000624	CcSEcCtD
Pentobarbital—Rash—Thalidomide—hematologic cancer	0.000166	0.000619	CcSEcCtD
Pentobarbital—Dermatitis—Thalidomide—hematologic cancer	0.000166	0.000619	CcSEcCtD
Pentobarbital—Dizziness—Alitretinoin—hematologic cancer	0.000166	0.000618	CcSEcCtD
Pentobarbital—Headache—Thalidomide—hematologic cancer	0.000165	0.000615	CcSEcCtD
Pentobarbital—Dizziness—Ifosfamide—hematologic cancer	0.000164	0.000611	CcSEcCtD
Pentobarbital—Nausea—Thiotepa—hematologic cancer	0.000162	0.000603	CcSEcCtD
Pentobarbital—Feeling abnormal—Etoposide—hematologic cancer	0.000161	0.000601	CcSEcCtD
Pentobarbital—Vomiting—Carmustine—hematologic cancer	0.000161	0.0006	CcSEcCtD
Pentobarbital—Dizziness—Vincristine—hematologic cancer	0.00016	0.000596	CcSEcCtD
Pentobarbital—Rash—Carmustine—hematologic cancer	0.00016	0.000595	CcSEcCtD
Pentobarbital—Dermatitis—Carmustine—hematologic cancer	0.000159	0.000594	CcSEcCtD
Pentobarbital—Vomiting—Alitretinoin—hematologic cancer	0.000159	0.000594	CcSEcCtD
Pentobarbital—Feeling abnormal—Prednisolone—hematologic cancer	0.000159	0.000593	CcSEcCtD
Pentobarbital—Headache—Carmustine—hematologic cancer	0.000158	0.000591	CcSEcCtD
Pentobarbital—Shock—Betamethasone—hematologic cancer	0.000158	0.000591	CcSEcCtD
Pentobarbital—Shock—Dexamethasone—hematologic cancer	0.000158	0.000591	CcSEcCtD
Pentobarbital—Rash—Alitretinoin—hematologic cancer	0.000158	0.000589	CcSEcCtD
Pentobarbital—Agitation—Prednisone—hematologic cancer	0.000158	0.000589	CcSEcCtD
Pentobarbital—Dermatitis—Alitretinoin—hematologic cancer	0.000158	0.000589	CcSEcCtD
Pentobarbital—Vomiting—Ifosfamide—hematologic cancer	0.000158	0.000587	CcSEcCtD
Pentobarbital—Hypersensitivity—Cisplatin—hematologic cancer	0.000157	0.000587	CcSEcCtD
Pentobarbital—Bradycardia—Epirubicin—hematologic cancer	0.000157	0.000586	CcSEcCtD
Pentobarbital—Headache—Alitretinoin—hematologic cancer	0.000157	0.000586	CcSEcCtD
Pentobarbital—Angioedema—Prednisone—hematologic cancer	0.000157	0.000585	CcSEcCtD
Pentobarbital—Nausea—Thalidomide—hematologic cancer	0.000156	0.000584	CcSEcCtD
Pentobarbital—Rash—Ifosfamide—hematologic cancer	0.000156	0.000582	CcSEcCtD
Pentobarbital—Dermatitis—Ifosfamide—hematologic cancer	0.000156	0.000582	CcSEcCtD
Pentobarbital—Dizziness—Irinotecan—hematologic cancer	0.000156	0.00058	CcSEcCtD
Pentobarbital—Body temperature increased—Etoposide—hematologic cancer	0.000155	0.000577	CcSEcCtD
Pentobarbital—Syncope—Prednisone—hematologic cancer	0.000154	0.000575	CcSEcCtD
Pentobarbital—Vomiting—Vincristine—hematologic cancer	0.000154	0.000573	CcSEcCtD
Pentobarbital—Rash—Vincristine—hematologic cancer	0.000152	0.000568	CcSEcCtD
Pentobarbital—Dermatitis—Vincristine—hematologic cancer	0.000152	0.000567	CcSEcCtD
Pentobarbital—Headache—Vincristine—hematologic cancer	0.000151	0.000564	CcSEcCtD
Pentobarbital—Loss of consciousness—Prednisone—hematologic cancer	0.000151	0.000563	CcSEcCtD
Pentobarbital—Hypotension—Dexamethasone—hematologic cancer	0.00015	0.000561	CcSEcCtD
Pentobarbital—Hypotension—Betamethasone—hematologic cancer	0.00015	0.000561	CcSEcCtD
Pentobarbital—Nausea—Carmustine—hematologic cancer	0.00015	0.00056	CcSEcCtD
Pentobarbital—Vomiting—Irinotecan—hematologic cancer	0.00015	0.000558	CcSEcCtD
Pentobarbital—Vomiting—Mitoxantrone—hematologic cancer	0.00015	0.000558	CcSEcCtD
Pentobarbital—Nausea—Alitretinoin—hematologic cancer	0.000149	0.000555	CcSEcCtD
Pentobarbital—Rash—Mitoxantrone—hematologic cancer	0.000148	0.000553	CcSEcCtD
Pentobarbital—Rash—Irinotecan—hematologic cancer	0.000148	0.000553	CcSEcCtD
Pentobarbital—Dermatitis—Mitoxantrone—hematologic cancer	0.000148	0.000553	CcSEcCtD
Pentobarbital—Dermatitis—Irinotecan—hematologic cancer	0.000148	0.000553	CcSEcCtD
Pentobarbital—Headache—Irinotecan—hematologic cancer	0.000147	0.00055	CcSEcCtD
Pentobarbital—Headache—Mitoxantrone—hematologic cancer	0.000147	0.00055	CcSEcCtD
Pentobarbital—Nausea—Ifosfamide—hematologic cancer	0.000147	0.000549	CcSEcCtD
Pentobarbital—Feeling abnormal—Triamcinolone—hematologic cancer	0.000146	0.000545	CcSEcCtD
Pentobarbital—Anxiety—Prednisone—hematologic cancer	0.000146	0.000544	CcSEcCtD
Pentobarbital—Vomiting—Gemcitabine—hematologic cancer	0.000146	0.000543	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—hematologic cancer	0.000145	0.000542	CcSEcCtD
Pentobarbital—Rash—Gemcitabine—hematologic cancer	0.000144	0.000539	CcSEcCtD
Pentobarbital—Dermatitis—Gemcitabine—hematologic cancer	0.000144	0.000538	CcSEcCtD
Pentobarbital—Hypersensitivity—Etoposide—hematologic cancer	0.000144	0.000538	CcSEcCtD
Pentobarbital—Headache—Gemcitabine—hematologic cancer	0.000144	0.000535	CcSEcCtD
Pentobarbital—Nausea—Vincristine—hematologic cancer	0.000143	0.000535	CcSEcCtD
Pentobarbital—Hypersensitivity—Prednisolone—hematologic cancer	0.000142	0.00053	CcSEcCtD
Pentobarbital—Body temperature increased—Triamcinolone—hematologic cancer	0.00014	0.000523	CcSEcCtD
Pentobarbital—Nausea—Mitoxantrone—hematologic cancer	0.00014	0.000521	CcSEcCtD
Pentobarbital—Nausea—Irinotecan—hematologic cancer	0.00014	0.000521	CcSEcCtD
Pentobarbital—Shock—Prednisone—hematologic cancer	0.000138	0.000514	CcSEcCtD
Pentobarbital—Nausea—Gemcitabine—hematologic cancer	0.000136	0.000508	CcSEcCtD
Pentobarbital—Vomiting—Cisplatin—hematologic cancer	0.000136	0.000506	CcSEcCtD
Pentobarbital—Rash—Cisplatin—hematologic cancer	0.000135	0.000502	CcSEcCtD
Pentobarbital—Dermatitis—Cisplatin—hematologic cancer	0.000135	0.000502	CcSEcCtD
Pentobarbital—Feeling abnormal—Dexamethasone—hematologic cancer	0.000133	0.000495	CcSEcCtD
Pentobarbital—Feeling abnormal—Betamethasone—hematologic cancer	0.000133	0.000495	CcSEcCtD
Pentobarbital—Tension—Epirubicin—hematologic cancer	0.000132	0.000492	CcSEcCtD
Pentobarbital—Hypersensitivity—Triamcinolone—hematologic cancer	0.000131	0.000488	CcSEcCtD
Pentobarbital—Nervousness—Epirubicin—hematologic cancer	0.000131	0.000487	CcSEcCtD
Pentobarbital—Dizziness—Etoposide—hematologic cancer	0.000129	0.000482	CcSEcCtD
Pentobarbital—Dizziness—Prednisolone—hematologic cancer	0.000128	0.000476	CcSEcCtD
Pentobarbital—Body temperature increased—Dexamethasone—hematologic cancer	0.000127	0.000475	CcSEcCtD
Pentobarbital—Body temperature increased—Betamethasone—hematologic cancer	0.000127	0.000475	CcSEcCtD
Pentobarbital—Nausea—Cisplatin—hematologic cancer	0.000127	0.000473	CcSEcCtD
Pentobarbital—Vomiting—Etoposide—hematologic cancer	0.000124	0.000464	CcSEcCtD
Pentobarbital—Agitation—Epirubicin—hematologic cancer	0.000123	0.000461	CcSEcCtD
Pentobarbital—Rash—Etoposide—hematologic cancer	0.000123	0.00046	CcSEcCtD
Pentobarbital—Dermatitis—Etoposide—hematologic cancer	0.000123	0.00046	CcSEcCtD
Pentobarbital—Headache—Etoposide—hematologic cancer	0.000123	0.000457	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—hematologic cancer	0.000122	0.000455	CcSEcCtD
Pentobarbital—Rash—Prednisolone—hematologic cancer	0.000122	0.000454	CcSEcCtD
Pentobarbital—Dermatitis—Prednisolone—hematologic cancer	0.000122	0.000453	CcSEcCtD
Pentobarbital—Headache—Prednisolone—hematologic cancer	0.000121	0.000451	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—hematologic cancer	0.000121	0.00045	CcSEcCtD
Pentobarbital—Syncope—Epirubicin—hematologic cancer	0.000121	0.000449	CcSEcCtD
Pentobarbital—Constipation—Prednisone—hematologic cancer	0.00012	0.000447	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—hematologic cancer	0.000118	0.000441	CcSEcCtD
Pentobarbital—Loss of consciousness—Epirubicin—hematologic cancer	0.000118	0.00044	CcSEcCtD
Pentobarbital—Dizziness—Triamcinolone—hematologic cancer	0.000117	0.000438	CcSEcCtD
Pentobarbital—Nausea—Etoposide—hematologic cancer	0.000116	0.000433	CcSEcCtD
Pentobarbital—Feeling abnormal—Prednisone—hematologic cancer	0.000116	0.000431	CcSEcCtD
Pentobarbital—Nausea—Prednisolone—hematologic cancer	0.000115	0.000427	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—hematologic cancer	0.000114	0.000426	CcSEcCtD
Pentobarbital—Anxiety—Epirubicin—hematologic cancer	0.000114	0.000425	CcSEcCtD
Pentobarbital—Vomiting—Triamcinolone—hematologic cancer	0.000113	0.000421	CcSEcCtD
Pentobarbital—Rash—Triamcinolone—hematologic cancer	0.000112	0.000417	CcSEcCtD
Pentobarbital—Dermatitis—Triamcinolone—hematologic cancer	0.000112	0.000417	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—hematologic cancer	0.000112	0.000416	CcSEcCtD
Pentobarbital—Headache—Triamcinolone—hematologic cancer	0.000111	0.000415	CcSEcCtD
Pentobarbital—Body temperature increased—Prednisone—hematologic cancer	0.000111	0.000413	CcSEcCtD
Pentobarbital—Confusional state—Epirubicin—hematologic cancer	0.000111	0.000412	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—hematologic cancer	0.00011	0.000408	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—hematologic cancer	0.000109	0.000408	CcSEcCtD
Pentobarbital—Shock—Epirubicin—hematologic cancer	0.000108	0.000402	CcSEcCtD
Pentobarbital—Dizziness—Betamethasone—hematologic cancer	0.000106	0.000397	CcSEcCtD
Pentobarbital—Dizziness—Dexamethasone—hematologic cancer	0.000106	0.000397	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—hematologic cancer	0.000105	0.000393	CcSEcCtD
Pentobarbital—Nausea—Triamcinolone—hematologic cancer	0.000105	0.000393	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—hematologic cancer	0.000104	0.000389	CcSEcCtD
Pentobarbital—Hypersensitivity—Prednisone—hematologic cancer	0.000103	0.000385	CcSEcCtD
Pentobarbital—Hypotension—Epirubicin—hematologic cancer	0.000102	0.000382	CcSEcCtD
Pentobarbital—Vomiting—Betamethasone—hematologic cancer	0.000102	0.000382	CcSEcCtD
Pentobarbital—Vomiting—Dexamethasone—hematologic cancer	0.000102	0.000382	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—hematologic cancer	0.000102	0.000382	CcSEcCtD
Pentobarbital—Rash—Betamethasone—hematologic cancer	0.000102	0.000379	CcSEcCtD
Pentobarbital—Rash—Dexamethasone—hematologic cancer	0.000102	0.000379	CcSEcCtD
Pentobarbital—Dermatitis—Dexamethasone—hematologic cancer	0.000101	0.000378	CcSEcCtD
Pentobarbital—Dermatitis—Betamethasone—hematologic cancer	0.000101	0.000378	CcSEcCtD
Pentobarbital—Headache—Dexamethasone—hematologic cancer	0.000101	0.000376	CcSEcCtD
Pentobarbital—Headache—Betamethasone—hematologic cancer	0.000101	0.000376	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—hematologic cancer	9.98e-05	0.000372	CcSEcCtD
Pentobarbital—Somnolence—Epirubicin—hematologic cancer	9.75e-05	0.000364	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—hematologic cancer	9.66e-05	0.00036	CcSEcCtD
Pentobarbital—Nausea—Betamethasone—hematologic cancer	9.56e-05	0.000357	CcSEcCtD
Pentobarbital—Nausea—Dexamethasone—hematologic cancer	9.56e-05	0.000357	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—hematologic cancer	9.48e-05	0.000354	CcSEcCtD
Pentobarbital—Constipation—Epirubicin—hematologic cancer	9.38e-05	0.00035	CcSEcCtD
Pentobarbital—Dizziness—Prednisone—hematologic cancer	9.27e-05	0.000346	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—hematologic cancer	9.26e-05	0.000345	CcSEcCtD
Pentobarbital—Feeling abnormal—Epirubicin—hematologic cancer	9.04e-05	0.000337	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—hematologic cancer	9.02e-05	0.000336	CcSEcCtD
Pentobarbital—Vomiting—Prednisone—hematologic cancer	8.92e-05	0.000332	CcSEcCtD
Pentobarbital—Rash—Prednisone—hematologic cancer	8.84e-05	0.00033	CcSEcCtD
Pentobarbital—Dermatitis—Prednisone—hematologic cancer	8.83e-05	0.000329	CcSEcCtD
Pentobarbital—Headache—Prednisone—hematologic cancer	8.78e-05	0.000328	CcSEcCtD
Pentobarbital—Constipation—Doxorubicin—hematologic cancer	8.68e-05	0.000324	CcSEcCtD
Pentobarbital—Body temperature increased—Epirubicin—hematologic cancer	8.67e-05	0.000323	CcSEcCtD
Pentobarbital—Hypersensitivity—Methotrexate—hematologic cancer	8.63e-05	0.000322	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—hematologic cancer	8.36e-05	0.000312	CcSEcCtD
Pentobarbital—Nausea—Prednisone—hematologic cancer	8.33e-05	0.000311	CcSEcCtD
Pentobarbital—Hypersensitivity—Epirubicin—hematologic cancer	8.08e-05	0.000301	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—hematologic cancer	8.02e-05	0.000299	CcSEcCtD
Pentobarbital—Dizziness—Methotrexate—hematologic cancer	7.75e-05	0.000289	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—hematologic cancer	7.48e-05	0.000279	CcSEcCtD
Pentobarbital—Vomiting—Methotrexate—hematologic cancer	7.45e-05	0.000278	CcSEcCtD
Pentobarbital—Rash—Methotrexate—hematologic cancer	7.39e-05	0.000276	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—hematologic cancer	7.38e-05	0.000275	CcSEcCtD
Pentobarbital—Headache—Methotrexate—hematologic cancer	7.34e-05	0.000274	CcSEcCtD
Pentobarbital—Dizziness—Epirubicin—hematologic cancer	7.25e-05	0.00027	CcSEcCtD
Pentobarbital—Vomiting—Epirubicin—hematologic cancer	6.97e-05	0.00026	CcSEcCtD
Pentobarbital—Nausea—Methotrexate—hematologic cancer	6.96e-05	0.00026	CcSEcCtD
Pentobarbital—Rash—Epirubicin—hematologic cancer	6.91e-05	0.000258	CcSEcCtD
Pentobarbital—Dermatitis—Epirubicin—hematologic cancer	6.91e-05	0.000258	CcSEcCtD
Pentobarbital—Headache—Epirubicin—hematologic cancer	6.87e-05	0.000256	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—hematologic cancer	6.71e-05	0.00025	CcSEcCtD
Pentobarbital—Nausea—Epirubicin—hematologic cancer	6.51e-05	0.000243	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—hematologic cancer	6.45e-05	0.000241	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—hematologic cancer	6.4e-05	0.000239	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—hematologic cancer	6.39e-05	0.000238	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—hematologic cancer	6.36e-05	0.000237	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—hematologic cancer	6.03e-05	0.000225	CcSEcCtD
Pentobarbital—CYP2A6—Metabolism—PC—hematologic cancer	2.72e-05	0.00029	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—MDM2—hematologic cancer	2.7e-05	0.000288	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—MDM2—hematologic cancer	2.68e-05	0.000286	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.66e-05	0.000285	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.66e-05	0.000284	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.65e-05	0.000283	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—MDM2—hematologic cancer	2.63e-05	0.000281	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GBA—hematologic cancer	2.62e-05	0.00028	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC35B2—hematologic cancer	2.62e-05	0.00028	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.62e-05	0.000279	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.61e-05	0.000279	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.6e-05	0.000278	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.57e-05	0.000275	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.56e-05	0.000273	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.56e-05	0.000273	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.55e-05	0.000273	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.54e-05	0.000271	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.51e-05	0.000268	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—HRAS—hematologic cancer	2.5e-05	0.000267	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—HRAS—hematologic cancer	2.5e-05	0.000267	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.49e-05	0.000266	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PHYH—hematologic cancer	2.48e-05	0.000265	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GMPS—hematologic cancer	2.48e-05	0.000265	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FTCD—hematologic cancer	2.48e-05	0.000265	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.46e-05	0.000263	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTAP—hematologic cancer	2.4e-05	0.000256	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	2.38e-05	0.000255	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.34e-05	0.00025	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.31e-05	0.000247	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—MDM2—hematologic cancer	2.3e-05	0.000246	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.28e-05	0.000244	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SMPD3—hematologic cancer	2.27e-05	0.000243	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TGFB1—hematologic cancer	2.27e-05	0.000242	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.27e-05	0.000242	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.25e-05	0.000241	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	2.2e-05	0.000236	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.19e-05	0.000234	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.18e-05	0.000233	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—FHL2—hematologic cancer	2.14e-05	0.000229	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.12e-05	0.000226	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—HRAS—hematologic cancer	2.1e-05	0.000225	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AGRN—hematologic cancer	2.1e-05	0.000224	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.06e-05	0.00022	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.06e-05	0.00022	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—HRAS—hematologic cancer	2.04e-05	0.000218	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.02e-05	0.000216	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—hematologic cancer	2e-05	0.000214	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.99e-05	0.000213	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—IDH2—hematologic cancer	1.99e-05	0.000212	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMMR—hematologic cancer	1.99e-05	0.000212	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ASNS—hematologic cancer	1.98e-05	0.000212	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—B3GAT1—hematologic cancer	1.98e-05	0.000212	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—DCK—hematologic cancer	1.98e-05	0.000212	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.97e-05	0.00021	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.95e-05	0.000208	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.94e-05	0.000207	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.93e-05	0.000206	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.92e-05	0.000206	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.92e-05	0.000205	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.92e-05	0.000205	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.89e-05	0.000202	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.89e-05	0.000201	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HDC—hematologic cancer	1.88e-05	0.000201	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ARNTL—hematologic cancer	1.87e-05	0.0002	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ALB—hematologic cancer	1.86e-05	0.000199	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.82e-05	0.000195	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ACP5—hematologic cancer	1.82e-05	0.000194	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CA9—hematologic cancer	1.82e-05	0.000194	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOR2—hematologic cancer	1.79e-05	0.000192	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.79e-05	0.000191	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.77e-05	0.000189	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.77e-05	0.000189	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.75e-05	0.000187	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—HRAS—hematologic cancer	1.75e-05	0.000187	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.74e-05	0.000186	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—HRAS—hematologic cancer	1.73e-05	0.000185	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CDA—hematologic cancer	1.72e-05	0.000184	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—IDH1—hematologic cancer	1.71e-05	0.000183	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.71e-05	0.000182	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.7e-05	0.000182	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.7e-05	0.000181	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCC3—hematologic cancer	1.69e-05	0.000181	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTO1—hematologic cancer	1.69e-05	0.000181	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TXN—hematologic cancer	1.69e-05	0.000181	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.67e-05	0.000178	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.66e-05	0.000177	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PC—hematologic cancer	1.66e-05	0.000177	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SPHK1—hematologic cancer	1.65e-05	0.000177	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.65e-05	0.000176	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.63e-05	0.000174	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GBA—hematologic cancer	1.6e-05	0.000171	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC35B2—hematologic cancer	1.6e-05	0.000171	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.6e-05	0.000171	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—UGT1A1—hematologic cancer	1.59e-05	0.00017	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.59e-05	0.00017	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—HRAS—hematologic cancer	1.58e-05	0.000169	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.56e-05	0.000167	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC22A1—hematologic cancer	1.55e-05	0.000165	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CRABP1—hematologic cancer	1.55e-05	0.000165	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—HRAS—hematologic cancer	1.53e-05	0.000164	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALOX5—hematologic cancer	1.51e-05	0.000161	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—HRAS—hematologic cancer	1.51e-05	0.000161	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PHYH—hematologic cancer	1.49e-05	0.00016	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FTCD—hematologic cancer	1.49e-05	0.00016	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GMPS—hematologic cancer	1.49e-05	0.00016	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—HRAS—hematologic cancer	1.48e-05	0.000158	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—HRAS—hematologic cancer	1.47e-05	0.000157	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTAP—hematologic cancer	1.46e-05	0.000156	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NUP98—hematologic cancer	1.46e-05	0.000156	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.46e-05	0.000156	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—HRAS—hematologic cancer	1.44e-05	0.000154	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ADCY7—hematologic cancer	1.42e-05	0.000151	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA3—hematologic cancer	1.42e-05	0.000151	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NUP214—hematologic cancer	1.41e-05	0.00015	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTR—hematologic cancer	1.38e-05	0.000147	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCG2—hematologic cancer	1.38e-05	0.000147	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.37e-05	0.000146	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.36e-05	0.000146	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ENO2—hematologic cancer	1.35e-05	0.000144	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—hematologic cancer	1.31e-05	0.00014	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FHL2—hematologic cancer	1.3e-05	0.000139	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SDC1—hematologic cancer	1.28e-05	0.000137	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AGRN—hematologic cancer	1.28e-05	0.000137	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—HRAS—hematologic cancer	1.26e-05	0.000135	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—IDH2—hematologic cancer	1.21e-05	0.00013	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMMR—hematologic cancer	1.21e-05	0.00013	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—DCK—hematologic cancer	1.19e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.19e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ASNS—hematologic cancer	1.19e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.14e-05	0.000122	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ARNTL—hematologic cancer	1.14e-05	0.000122	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HDC—hematologic cancer	1.13e-05	0.000121	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA9—hematologic cancer	1.11e-05	0.000118	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACP5—hematologic cancer	1.11e-05	0.000118	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOR2—hematologic cancer	1.09e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NQO1—hematologic cancer	1.09e-05	0.000116	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CD44—hematologic cancer	1.09e-05	0.000116	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—IDH1—hematologic cancer	1.04e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CDA—hematologic cancer	1.03e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYCS—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TXN—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTO1—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCC3—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	1.02e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SPHK1—hematologic cancer	1.01e-05	0.000108	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PC—hematologic cancer	9.96e-06	0.000106	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UGT1A1—hematologic cancer	9.69e-06	0.000104	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC35B2—hematologic cancer	9.62e-06	0.000103	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GBA—hematologic cancer	9.62e-06	0.000103	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC22A1—hematologic cancer	9.43e-06	0.000101	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CRABP1—hematologic cancer	9.43e-06	0.000101	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALOX5—hematologic cancer	9.19e-06	9.82e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—hematologic cancer	9.09e-06	9.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NUP98—hematologic cancer	8.9e-06	9.51e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTAP—hematologic cancer	8.8e-06	9.4e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA3—hematologic cancer	8.64e-06	9.23e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ADCY7—hematologic cancer	8.64e-06	9.23e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCB1—hematologic cancer	8.6e-06	9.19e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NUP214—hematologic cancer	8.58e-06	9.17e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.49e-06	9.07e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCG2—hematologic cancer	8.4e-06	8.98e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTR—hematologic cancer	8.4e-06	8.98e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—hematologic cancer	8.35e-06	8.92e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOR1—hematologic cancer	8.35e-06	8.92e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ENO2—hematologic cancer	8.24e-06	8.81e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.99e-06	8.54e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.87e-06	8.41e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FHL2—hematologic cancer	7.84e-06	8.38e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SDC1—hematologic cancer	7.81e-06	8.35e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AGRN—hematologic cancer	7.69e-06	8.22e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.46e-06	7.97e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—hematologic cancer	7.38e-06	7.89e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.37e-06	7.87e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMMR—hematologic cancer	7.29e-06	7.79e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—IDH2—hematologic cancer	7.29e-06	7.79e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.05e-06	7.53e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.85e-06	7.32e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA9—hematologic cancer	6.67e-06	7.12e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACP5—hematologic cancer	6.67e-06	7.12e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NQO1—hematologic cancer	6.64e-06	7.1e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CD44—hematologic cancer	6.64e-06	7.1e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.58e-06	7.03e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.5e-06	6.95e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYCS—hematologic cancer	6.29e-06	6.72e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—IDH1—hematologic cancer	6.27e-06	6.7e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	6.25e-06	6.67e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CG—hematologic cancer	6.2e-06	6.63e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TXN—hematologic cancer	6.2e-06	6.62e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.2e-06	6.62e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.2e-06	6.62e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.07e-06	6.48e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.83e-06	6.23e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CREBBP—hematologic cancer	5.75e-06	6.14e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.67e-06	6.06e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.67e-06	6.06e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.62e-06	6.01e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.54e-06	5.92e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.52e-06	5.9e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CD—hematologic cancer	5.45e-06	5.82e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALB—hematologic cancer	5.38e-06	5.75e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.36e-06	5.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NUP98—hematologic cancer	5.35e-06	5.72e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCB1—hematologic cancer	5.24e-06	5.6e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.19e-06	5.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.19e-06	5.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NUP214—hematologic cancer	5.16e-06	5.51e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3R1—hematologic cancer	5.15e-06	5.5e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOR1—hematologic cancer	5.09e-06	5.44e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—hematologic cancer	5.09e-06	5.44e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTR—hematologic cancer	5.05e-06	5.4e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.05e-06	5.4e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ENO2—hematologic cancer	4.96e-06	5.3e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.81e-06	5.14e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CB—hematologic cancer	4.75e-06	5.08e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SDC1—hematologic cancer	4.7e-06	5.02e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.5e-06	4.81e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTEN—hematologic cancer	4.11e-06	4.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CD44—hematologic cancer	3.99e-06	4.27e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NQO1—hematologic cancer	3.99e-06	4.27e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.97e-06	4.24e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—EP300—hematologic cancer	3.92e-06	4.18e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.78e-06	4.04e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYCS—hematologic cancer	3.78e-06	4.04e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.76e-06	4.01e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.5e-06	3.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.33e-06	3.56e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.32e-06	3.55e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALB—hematologic cancer	3.28e-06	3.51e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.15e-06	3.37e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.14e-06	3.35e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.06e-06	3.27e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.06e-06	3.27e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.9e-06	3.1e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CA—hematologic cancer	2.9e-06	3.09e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.71e-06	2.89e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTEN—hematologic cancer	2.5e-06	2.67e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—EP300—hematologic cancer	2.39e-06	2.55e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKT1—hematologic cancer	2.37e-06	2.53e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.27e-06	2.43e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.11e-06	2.25e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2e-06	2.14e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALB—hematologic cancer	1.97e-06	2.11e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.89e-06	2.02e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.77e-06	1.89e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.74e-06	1.86e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTEN—hematologic cancer	1.51e-06	1.61e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKT1—hematologic cancer	1.44e-06	1.54e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—EP300—hematologic cancer	1.44e-06	1.53e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.13e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKT1—hematologic cancer	8.67e-07	9.27e-06	CbGpPWpGaD
